Lubiprostone Patent Expiration
Lubiprostone is Used for treating constipation, irritable bowel syndrome, and abdominal discomfort associated with irritable bowel syndrome. It was first introduced by Sucampo Pharma Americas Llc
Lubiprostone Patents
Given below is the list of patents protecting Lubiprostone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Amitiza | US8026393 | Soft-gelatin capsule formulation | Oct 25, 2027 | Sucampo Pharma Llc |
| Amitiza | US8338639 | Soft-gelatin capsule formulation | Jan 23, 2027 | Sucampo Pharma Llc |
| Amitiza | US8779187 | Soft-gelatin capsule formulation | Jan 23, 2027 | Sucampo Pharma Llc |
| Amitiza | US8748481 | Method for treating gastrointestinal disorder | Sep 01, 2025 | Sucampo Pharma Llc |
| Amitiza | US7795312 | Method for treating abdominal discomfort |
Sep 17, 2024
(Expired) | Sucampo Pharma Llc |
| Amitiza | US6982283 | Method for treating drug-induced constipation |
Dec 04, 2022
(Expired) | Sucampo Pharma Llc |
| Amitiza | US8097653 | Dosage unit comprising a prostaglandin analog for treating constipation |
Nov 14, 2022
(Expired) | Sucampo Pharma Llc |
| Amitiza | US8389542 | Dosage unit comprising a prostaglandin analog for treating constipation |
Nov 14, 2022
(Expired) | Sucampo Pharma Llc |
| Amitiza | US7064148 | Chloride channel opener |
Aug 30, 2022
(Expired) | Sucampo Pharma Llc |
| Amitiza | US8088934 | Composition and method for stabilizing the same |
May 18, 2021
(Expired) | Sucampo Pharma Llc |
| Amitiza | US6583174 | Composition and method for stabilizing the same |
Oct 16, 2020
(Expired) | Sucampo Pharma Llc |
| Amitiza | US7417067 | Composition and method for stabilizing the same |
Oct 16, 2020
(Expired) | Sucampo Pharma Llc |
| Amitiza | US8097649 | Composition and method for stabilizing the same |
Oct 16, 2020
(Expired) | Sucampo Pharma Llc |
| Amitiza | US6414016 | Anti-constipation composition |
Sep 05, 2020
(Expired) | Sucampo Pharma Llc |
| Amitiza | US8071613 | Anti-constipation composition |
Sep 05, 2020
(Expired) | Sucampo Pharma Llc |
| Amitiza | US8114890 | Anti-constipation composition |
Sep 05, 2020
(Expired) | Sucampo Pharma Llc |
| Amitiza | US5284858 | Prostaglandins E and anti ulcers containing same |
Jul 14, 2014
(Expired) | Sucampo Pharma Llc |
Lubiprostone's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List